Primary record
cyclopentanepentanoic acid, 3,5-dihydroxy-2-(3-hydroxy-1-octenyl)-gamma-oxo-, (1R-(1 alpha,2 beta(1E,3S*),3 alpha,5 alpha))-
- 库存
- 5,588 克
- 纯度
- 99.7 %
- CAS
- 64700-71-6
化合物标识与属性
- CAS
- 64700-71-6
- PubChem CID
- 5283084
- SMILES
- CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1CC(=O)CCC(=O)O)O)O)O
- Canonical SMILES
- CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](CC(=O)CCC(=O)O)[C@@H](O)C[C@H]1O
名称与同义词
- 2,3-Dkpgf1alpha
- Pgi2-M
- 2,3-Dinor-6-oxo-pgf1alpha
- 2,3-Dinor-6-keto-pgf1alpha
- 2,3-Dinor-6-oxoprostaglandin F1alpha
- 2,3-Dinor-6-ketoprostaglandin F1alpha
- PGF1alpha, 6-oxo
- 2,3-dinor, 6-keto-PGF1alpha
- AC1NR1HM
- 64700-71-6
- RefChem:908664
- 2,3d-6K-PGF1alpha
- 2,3-DKPGF1a
- DTXSID301314213
- 2,3-dinor-6-Keto prostaglandin F1alpha
- 2,3-Dinor-6-oxo-PGF1a
- CHEBI:73944
- 2,3-Dinor-6-ketoPGF1alpha
- 2.3-Dinitro-1-hydroxy-benzol
- BML1-G08
- 2,3-Dinor, 6-keto-PGF1a
- 2,3-DINOR-6-KETO-PGF1a
- BDBM82096
- DNKGWNLXBRCUCF-NLOSNHEGSA-N
- Bio1_000279
- DTXCID301744024
- 2,3-Dinor-6-keto-PGF1I+/-
- 2,3-Dinor-6-oxoprostaglandin F1a
- C18H30O6
- ZINC5820797
- 2,3-dinor-6-ketoprostaglandin F1a
- 2,3-dinor-6-oxo-prostaglandin F1alpha
- 1336AH
- 2,3-Dinor-6-oxo-prostaglandin F1a
- LMFA03010089
- 2,3-dinor, 6-keto-Prostaglandin F1alpha
- 2,3-Dinor-6-keto Prostaglandin F1?
- 2,3-Dinor-6-keto Prostaglandin F1a
- (1R,2R,3R,5S)-
- C18-H30-O6
- CID5283084
- 2,3-Dinor-6-keto Prostaglandin F1|A
- CID:5283084
- 2,3-Dinor-17-dehydro-6-ketoPGF1alpha
- 2,3-Dinor-6-keto-prostaglandin F1alpha
- NCGC00161295-01
- PD052952
- SID:134222103
- CAS_64700-71-6
- DB-222553
- J246.646E
- FT-0667603
- 5-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]-4-oxopentanoic acid
- C028290
- Q27144266
- 6-oxo-9S,11R,15S-trihydroxy-2,3-dinor-13E-prostaenoic acid
- 5-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl}-4-oxopentanoic acid
- Cyclopentanepentanoic acid, 3,5-dihydroxy-2-((1E,3S)-3-hydroxy-1-octenyl)-gamma-oxo-, (1R,2R,3R,5S)-
- cyclopentanepentanoic acid, 3,5-dihydroxy-2-(3-hydroxy-1-octenyl)-gamma-oxo-, (1R-(1 alpha,2 beta(1E,3S*),3 alpha,5 alpha))-
- Cyclopentanepentanoic acid, 3,5-dihydroxy-2-(3-hydroxy-1-octenyl)-gamma-oxo-, (1R-(1alpha,2beta(1E,3S*),3alpha,5alpha))-
- (13E,15S)-9alpha,11alpha,15-trihydroxy-2,3-dinor-6-oxoprost-13-en-1-oic acid
- (13E,15S)-9alpha,11alpha,15-Trihydroxy-6-oxo-2,3-dinorprost-13-en-1-oic acid
- (1R,2r,3r,5s)-3,5-dihydroxy-2-[(1e,3s)-3-hydroxy-1-octen-1-yl]-gamma-oxo-cyclopentanepentanoicacid
- 5-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-4-oxopentanoic acid
- Cyclopentanepentanoicacid, 3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-1-octen-1-yl]-g-oxo-, (1R,2R,3R,5S)-
- Cyclopentanepentanoicacid,3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-1-octen-1-yl]-g-oxo-,(1R,2R,3R,5S)-